Skip to main content
All lobbying filings

BURRELL INTERNATIONAL GROUP LLC

Lobbying for TONIX PHARMACEUTICALS HOLDING CORP. · Pharmaceutical Company

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate · $40,000.00 income · posted Apr 17, 2026

Official filing document

 Lobbying activity 1
Pharmacy

LHHS Appropriation R&D Funding, Pandemic Preparedness Funding for Next Generation Products; FY27 Defense Appropriation for broad-spectrum antivirals, FY27 FDA-AG for cocaine overdose funding; Alternative to Pain Act and Chronic Pain coverage

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem